Chunling Liu

机构：Shenzhen Bao'an District People's Hospital · ORCID：0000-0003-0119-6255

发表论文 81 篇 · 总被引 657 次 · h-index 15

代表论文

• Hierarchical ZnIn2S4: A promising cocatalyst to boost visible-light-driven photocatalytic hydrogen evolution of In(OH)3 (2019 · International Journal of Hydrogen Energy · 被引 55)
• Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE) (2024 · Journal of Thoracic Oncology · 被引 40)
• Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC (2023 · Nature Cancer · 被引 34)
• Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies (2023 · BMC Medicine · 被引 23)
• Steel Surface Defect Detection Based on YOLOv8-TLC (2024 · Applied Sciences · 被引 18)
• Efficacy and safety of alflutinib (AST2818) in patients with T790M mutation-positive NSCLC: A phase IIb multicenter single-arm study. (2020 · Journal of Clinical Oncology · 被引 13)